Jon D Levine Selected Research

Alcoholic Neuropathy (Alcoholic Polyneuropathy)

7/2011	Muscle pain in models of chemotherapy-induced and alcohol-induced peripheral neuropathy.
10/2010	Attenuation of activity in an endogenous analgesia circuit by ongoing pain in the rat.
9/2008	Neurotoxic catecholamine metabolite in nociceptors contributes to painful peripheral neuropathy.
7/2006	Ethanol withdrawal induces hyperalgesia mediated by PKCepsilon.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jon D Levine Research Topics

Disease

103	Hyperalgesia 01/2022 - 07/2002
83	Pain (Aches) 06/2022 - 07/2002
35	Neoplasms (Cancer) 01/2023 - 01/2004
29	Peripheral Nervous System Diseases (PNS Diseases) 01/2022 - 01/2004
24	Chronic Pain 12/2018 - 12/2007
22	Neuralgia (Stump Neuralgia) 01/2022 - 01/2004
20	Fatigue 04/2022 - 06/2012
19	Breast Neoplasms (Breast Cancer) 05/2022 - 05/2012
18	Lung Neoplasms (Lung Cancer) 06/2022 - 08/2015
12	Syndrome (Syndromes) 08/2022 - 06/2012
12	Inflammation (Inflammations) 01/2021 - 05/2003
11	Myalgia 01/2021 - 05/2008
7	Nausea 05/2022 - 01/2018
7	Gastrointestinal Neoplasms (Gastrointestinal Cancer) 03/2022 - 02/2017
7	Acquired Immunodeficiency Syndrome (AIDS) 08/2011 - 01/2004
6	Postoperative Pain 01/2019 - 03/2003
6	Mastodynia 11/2017 - 05/2012
4	Musculoskeletal Pain 01/2021 - 04/2010
4	Fibromyalgia (Fibrositis) 01/2021 - 10/2010
4	Alcoholism (Alcohol Abuse) 11/2013 - 06/2005
4	Alcoholic Neuropathy (Alcoholic Polyneuropathy) 07/2011 - 07/2006
4	Burns 03/2008 - 12/2006
3	Vomiting 05/2022 - 01/2020
3	Hypersensitivity (Allergy) 10/2021 - 01/2004
3	Hearing Loss (Hearing Impairment) 02/2018 - 01/2018
3	Tinnitus 02/2018 - 01/2018
3	Necrosis 09/2011 - 05/2003

Drug/Important Bio-Agent (IBA)

34	OligodeoxyribonucleotidesIBA 01/2022 - 02/2004
30	Dinoprostone (PGE2)FDA Link 10/2021 - 05/2003
21	ProstaglandinsIBA 01/2022 - 10/2002
18	Opioid Analgesics (Opioids)IBA 10/2021 - 10/2002
18	CytokinesIBA 01/2018 - 03/2008
16	Paclitaxel (Taxol)FDA LinkGeneric 01/2022 - 02/2004
16	Messenger RNA (mRNA)IBA 10/2021 - 07/2008
14	Protein Kinase C-epsilonIBA 01/2016 - 02/2003
13	Epinephrine (Adrenaline)FDA LinkGeneric 10/2018 - 02/2003
12	Protein Kinases (Protein Kinase)IBA 01/2016 - 05/2005
11	Analgesics (Analgesic Drugs)IBA 01/2022 - 03/2003
10	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2022 - 05/2008
10	Estrogens (Estrogen)FDA Link 01/2021 - 09/2003
9	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2021 - 05/2003
9	Interleukin-6 (Interleukin 6)IBA 01/2019 - 03/2008
9	Nerve Growth Factor (NGF)IBA 01/2018 - 06/2005
9	Cyclic AMP-Dependent Protein Kinases (cAMP-Dependent Protein Kinase)IBA 01/2017 - 10/2002
9	CarrageenanIBA 02/2012 - 05/2003
8	mu Opioid Receptors (mu Opioid Receptor)IBA 01/2019 - 03/2010
8	Protein Kinase CIBA 01/2019 - 10/2002
7	Hyaluronic Acid (Hyaluronan)IBA 01/2022 - 10/2018
7	Pharmaceutical PreparationsIBA 10/2019 - 06/2003
6	Morphine (MS Contin)FDA LinkGeneric 01/2022 - 08/2002
6	Ion Channels (Ion Channel)IBA 01/2021 - 05/2004
6	LectinsIBA 01/2019 - 06/2005
6	Proteins (Proteins, Gene)FDA Link 01/2017 - 02/2004
6	IntegrinsIBA 01/2015 - 02/2004
6	Zalcitabine (Hivid)FDA Link 08/2011 - 01/2004
6	BradykininIBA 07/2005 - 10/2002
5	Fentanyl (Sublimaze)FDA LinkGeneric 01/2022 - 01/2018
5	PlatinumIBA 01/2022 - 05/2008
5	GTP-Binding Proteins (G-Protein)IBA 01/2022 - 06/2011
5	AntiemeticsIBA 01/2021 - 01/2018
5	Opioid Receptors (Opioid Receptor)IBA 01/2021 - 04/2008
5	Interleukin-6 Receptors (Interleukin 6 Receptor)IBA 01/2019 - 09/2011
5	Ala(2)-MePhe(4)-Gly(5)- Enkephalin (DAGO)IBA 05/2018 - 03/2010
5	Narcotic Antagonists (Opioid Antagonists)IBA 01/2017 - 03/2003
5	InterleukinsIBA 01/2017 - 03/2008
5	Naloxone (Narcan)FDA LinkGeneric 01/2017 - 03/2003
5	Endothelin-1 (Endothelin 1)IBA 10/2015 - 01/2012
5	Ethanol (Ethyl Alcohol)IBA 07/2011 - 07/2006
5	Prostaglandins EIBA 09/2010 - 08/2003
5	Nalbuphine (Nubain)FDA LinkGeneric 04/2008 - 03/2003
4	Phosphotransferases (Kinase)IBA 10/2021 - 06/2005
4	Glucocorticoid Receptors (Glucocorticoid Receptor)IBA 01/2021 - 01/2008
4	Adenosine (Adenocard)FDA LinkGeneric 01/2017 - 03/2006
4	Glial Cell Line-Derived Neurotrophic Factor (GDNF)IBA 10/2013 - 07/2008
4	Reverse Transcriptase InhibitorsIBA 09/2010 - 01/2004
4	NucleosidesIBA 09/2010 - 01/2004
3	Hyaluronan ReceptorsIBA 01/2022 - 01/2021
3	taxaneIBA 01/2022 - 01/2018
3	Protein Isoforms (Isoforms)IBA 10/2021 - 06/2005
3	CalciumIBA 10/2021 - 01/2004
3	Toll-Like Receptor 4IBA 10/2021 - 01/2019
3	CorticosteroneIBA 01/2021 - 10/2009
3	PotassiumIBA 01/2019 - 03/2014
3	LigandsIBA 11/2017 - 12/2004
3	Potassium Channels (Potassium Channel)IBA 03/2017 - 03/2014
3	Estrogen ReceptorsIBA 01/2017 - 06/2011
3	Interleukin-10 (Interleukin 10)IBA 01/2017 - 02/2014
3	EnkephalinsIBA 03/2016 - 10/2002
3	LipidsIBA 01/2015 - 05/2005
3	Adenosine Triphosphate (ATP)IBA 07/2014 - 03/2006
3	AntioxidantsIBA 08/2011 - 05/2008
3	Reactive Oxygen Species (Oxygen Radicals)IBA 08/2011 - 07/2010

Therapy/Procedure

86	Drug Therapy (Chemotherapy) 01/2023 - 05/2004
20	Therapeutics 01/2022 - 01/2004
12	Analgesia 01/2022 - 03/2003
11	Intradermal Injections 01/2016 - 02/2004
7	Spinal Injections 11/2011 - 01/2004
5	Vagotomy 10/2003 - 10/2002
4	Intramuscular Injections 03/2020 - 09/2010
3	Castration 01/2021 - 05/2003